Gene therapy: present status and future prospects
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
London
Financial Times Pharmaceuticals & Healthcare Publ.
1995
|
Schriftenreihe: | Financial Times management reports
|
Schlagworte: | |
Beschreibung: | 83 S. |
ISBN: | 1853343110 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV010752118 | ||
003 | DE-604 | ||
005 | 19960514 | ||
007 | t | ||
008 | 960514s1995 |||| 00||| eng d | ||
020 | |a 1853343110 |9 1-85334-311-0 | ||
035 | |a (OCoLC)35595173 | ||
035 | |a (DE-599)BVBBV010752118 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
050 | 0 | |a RB155.8 | |
084 | |a WG 7400 |0 (DE-625)148616: |2 rvk | ||
100 | 1 | |a Evers, Paul |e Verfasser |4 aut | |
245 | 1 | 0 | |a Gene therapy |b present status and future prospects |c Paul Evers |
264 | 1 | |a London |b Financial Times Pharmaceuticals & Healthcare Publ. |c 1995 | |
300 | |a 83 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Financial Times management reports | |
650 | 7 | |a Clinical medicine |2 sigle | |
650 | 7 | |a Genetics, cytology and molecular biology |2 sigle | |
650 | 4 | |a Gene Therapy | |
650 | 4 | |a Gene therapy | |
650 | 4 | |a Genetic Engineering | |
650 | 4 | |a Genetic engineering | |
650 | 0 | 7 | |a Gentherapie |0 (DE-588)4296957-8 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4151278-9 |a Einführung |2 gnd-content | |
689 | 0 | 0 | |a Gentherapie |0 (DE-588)4296957-8 |D s |
689 | 0 | |5 DE-604 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-007180656 |
Datensatz im Suchindex
_version_ | 1804125232367140864 |
---|---|
any_adam_object | |
author | Evers, Paul |
author_facet | Evers, Paul |
author_role | aut |
author_sort | Evers, Paul |
author_variant | p e pe |
building | Verbundindex |
bvnumber | BV010752118 |
callnumber-first | R - Medicine |
callnumber-label | RB155 |
callnumber-raw | RB155.8 |
callnumber-search | RB155.8 |
callnumber-sort | RB 3155.8 |
callnumber-subject | RB - Pathology |
classification_rvk | WG 7400 |
ctrlnum | (OCoLC)35595173 (DE-599)BVBBV010752118 |
discipline | Biologie |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01277nam a2200409 c 4500</leader><controlfield tag="001">BV010752118</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19960514 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">960514s1995 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1853343110</subfield><subfield code="9">1-85334-311-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)35595173</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010752118</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RB155.8</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WG 7400</subfield><subfield code="0">(DE-625)148616:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Evers, Paul</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gene therapy</subfield><subfield code="b">present status and future prospects</subfield><subfield code="c">Paul Evers</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Financial Times Pharmaceuticals & Healthcare Publ.</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">83 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Financial Times management reports</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical medicine</subfield><subfield code="2">sigle</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genetics, cytology and molecular biology</subfield><subfield code="2">sigle</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gene Therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gene therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic Engineering</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic engineering</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gentherapie</subfield><subfield code="0">(DE-588)4296957-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4151278-9</subfield><subfield code="a">Einführung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Gentherapie</subfield><subfield code="0">(DE-588)4296957-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007180656</subfield></datafield></record></collection> |
genre | (DE-588)4151278-9 Einführung gnd-content |
genre_facet | Einführung |
id | DE-604.BV010752118 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T17:58:17Z |
institution | BVB |
isbn | 1853343110 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007180656 |
oclc_num | 35595173 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 83 S. |
publishDate | 1995 |
publishDateSearch | 1995 |
publishDateSort | 1995 |
publisher | Financial Times Pharmaceuticals & Healthcare Publ. |
record_format | marc |
series2 | Financial Times management reports |
spelling | Evers, Paul Verfasser aut Gene therapy present status and future prospects Paul Evers London Financial Times Pharmaceuticals & Healthcare Publ. 1995 83 S. txt rdacontent n rdamedia nc rdacarrier Financial Times management reports Clinical medicine sigle Genetics, cytology and molecular biology sigle Gene Therapy Gene therapy Genetic Engineering Genetic engineering Gentherapie (DE-588)4296957-8 gnd rswk-swf (DE-588)4151278-9 Einführung gnd-content Gentherapie (DE-588)4296957-8 s DE-604 |
spellingShingle | Evers, Paul Gene therapy present status and future prospects Clinical medicine sigle Genetics, cytology and molecular biology sigle Gene Therapy Gene therapy Genetic Engineering Genetic engineering Gentherapie (DE-588)4296957-8 gnd |
subject_GND | (DE-588)4296957-8 (DE-588)4151278-9 |
title | Gene therapy present status and future prospects |
title_auth | Gene therapy present status and future prospects |
title_exact_search | Gene therapy present status and future prospects |
title_full | Gene therapy present status and future prospects Paul Evers |
title_fullStr | Gene therapy present status and future prospects Paul Evers |
title_full_unstemmed | Gene therapy present status and future prospects Paul Evers |
title_short | Gene therapy |
title_sort | gene therapy present status and future prospects |
title_sub | present status and future prospects |
topic | Clinical medicine sigle Genetics, cytology and molecular biology sigle Gene Therapy Gene therapy Genetic Engineering Genetic engineering Gentherapie (DE-588)4296957-8 gnd |
topic_facet | Clinical medicine Genetics, cytology and molecular biology Gene Therapy Gene therapy Genetic Engineering Genetic engineering Gentherapie Einführung |
work_keys_str_mv | AT everspaul genetherapypresentstatusandfutureprospects |